Dr. Om Srivastava received his degree in Medicinal Chemistry in 1983 and joined the Ole Hindsgaul group at the University of Alberta, Canada. In 1987, he joined Alberta based ChemBioMed Ltd., where, as a Senior Research Scientist and a group leader, he was involved in the synthetic and development aspects of complex carbohydrates with the major focus on blood group determinants, tumor associated antigens, and cell adhesion molecules for selectins.
He has worked at the Alberta Research Council and has led a program to develop treatments for arthritis, asthma, bacterial and viral diseases. In 1994, he was honored as the Distinguished Scientist at the Alberta Research Council and was responsible for the development of Science and Technology for the Province of Alberta, Canada.
He has more than 75 Scientific Publications, Patents and Conference Proceedings. He has presented several invited lectures at international conferences.